Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2023
The sodium glucose co-transporter 2 inhibitor dapagliflozin ameliorates the fluid-retaining effect of the endothelin A receptor antagonist zibotentanVandana Veenit, Hiddo J L Heerspink, Christine Ahlström, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2015
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes InsipidusYue Zhang, Janos Peti-Peterdi, Christa E Müller, et al.
American Journal of Physiology. Renal Physiology|October 3, 2008
Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout miceYue Zhang, Jeff M Sands, Donald E Kohan, et al.
The New England Journal of Medicine|October 26, 2024
Atrasentan in Patients with IgA NephropathyHiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Cardiovascular Diabetology|September 16, 2023
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney diseaseJ David Smeijer, Donald E Kohan, Peter Rossing, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2015
Regulation of Mg2+ Reabsorption and Transient Receptor Potential Melastatin Type 6 Activity by cAMP SignalingMaxime G Blanchard, Wararat Kittikulsuth, Anil V Nair, et al.
Kidney International Reports|April 30, 2025
Corrigendum to "Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy" [Volume 10, Issue 1, January 2025, Pages 217-226]Hiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International Reports|January 15, 2025
Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA NephropathyHiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
Development (Cambridge, England)|August 28, 2009
beta1 integrin is necessary for ureteric bud branching morphogenesis and maintenance of collecting duct structural integrityXi Zhang, Glenda Mernaugh, Dong-Hua Yang, et al.
Pageof 16